Order to fund the minimum for option period 1 for master cell bank testing
Ended Awarded Last action
- Contract number
- HHSN26100005
- Awardee
-
Bioreliance Corporation UEI H3KAG9A26K77 Part of Sigma-Aldrich Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $94,587
Award facts
- Opportunity
-
- N02RC3600485 Solicitation number
- Biosafety Testing of GMP Master Cell Banks (MCB) and Retroviral Vectors for NCI Clinical Trials Award Notice · Posted Mar 7, 2013
- Contract value 100% obligated
- $94,587.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for an order to fund the minimum for Option Period 1 for master cell bank testing, awarded to Bioreliance Corporation, a foreign-owned, for-profit organization that provides specialized testing services to the U.S. government. The contract, issued by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), has a firm fixed price of $94,587.25 and a completion date of July 24, 2015. Bioreliance Corporation, through its Life Sciences Services Division, has extensive experience supporting government health initiatives, including providing services such as endotoxin testing, sterility testing, and general safety testing for pharmaceutical and biotechnology research and development. This order does not have a set-aside designation, indicating Bioreliance's strong competitive standing in its field.
Quick answers
Who was awarded contract HHSN26100005?
HHSN26100005 was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on July 21, 2014.
How much is contract HHSN26100005 worth?
The government has obligated $94,587 on HHSN26100005.
Is contract HHSN26100005 an order under another contract?
Yes. HHSN26100005 is a delivery order under HHSN261201300026I, an indefinite delivery contract.
Was contract HHSN26100005 competed?
The extent of competition for HHSN26100005 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award